cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.13521327.v1
title: Effectiveness of intermittent fasting to potentiate weight loss or muscle gains in humans younger than 60 years old: a systematic review

description: The aim was to determinate if the intermittent fasting enhances weight loss or muscle gains in humans younger than 60 years old. Multiple databases were searched up to May 2020 for studies in English, using MeSH terms and text words relating intermittent fasting, weight loss and muscle gains. The protocol was registered in PROSPERO. Study quality was assessed using NICE methodology. A total of 10 original articles were evaluated. Eight papers collected data through randomised controlled trials and two from cross-sectional study. Intermittent fasting could be beneficial in resistance trained subjects or in overweight individuals to improve body composition by decreasing fat mass and at least maintain muscle mass; decrease in GLP-1 levels and; improving health-related biomarkers such glucose and insulin levels. However, future studies are needed in order to better elucidate the effect of intermittent fasting on body composition.
DOI: 10.6084/m9.figshare.13730508
title: Reproducibility and validity of a food-frequency questionnaire (NFFQ) to assess food consumption based on the NOVA classification in adults

description: NOVA is a classification that divides foods into four groups according to processing. Since no questionnaires have been validated to assess the consumption of foods with different levels of processing in the general adult population, we tested the reliability and validity of a 94-item Food Frequency Questionnaire (NFFQ) designed to estimate the intake (g/day) and the weight ratio (%) of the NOVA food groups in Italian adults. Time reliability and validity were tested by administrating the NFFQ to 110 subjects on two different occasions and comparing it with a weighed dietary record (WDR). Strong correlations between NFFQs (<i>r</i> &gt; 0.7, <i>p</i> r
DOI: 10.6084/m9.figshare.13730508.v1
title: Reproducibility and validity of a food-frequency questionnaire (NFFQ) to assess food consumption based on the NOVA classification in adults

description: NOVA is a classification that divides foods into four groups according to processing. Since no questionnaires have been validated to assess the consumption of foods with different levels of processing in the general adult population, we tested the reliability and validity of a 94-item Food Frequency Questionnaire (NFFQ) designed to estimate the intake (g/day) and the weight ratio (%) of the NOVA food groups in Italian adults. Time reliability and validity were tested by administrating the NFFQ to 110 subjects on two different occasions and comparing it with a weighed dietary record (WDR). Strong correlations between NFFQs (<i>r</i> &gt; 0.7, <i>p</i> r
DOI: 10.15468/agrmfz
title: A new erythroneurine leafhopper genus from China (Hemiptera: Cicadellidae: Typhlocybinae)

description: This dataset contains the digitized treatments in Plazi based on the original journal article Song, Yue-Hua, Li, Zi-Zhong (2013): A new erythroneurine leafhopper genus from China (Hemiptera: Cicadellidae: Typhlocybinae). Zootaxa 3722 (4): 596-598, DOI: http://dx.doi.org/10.11646/zootaxa.3722.4.9
DOI: 10.25345/c5q83x
title: MassIVE MSV000088024 - Metabolite profiling of Hemigraphis alternata
title: Plant metabolomics is an emerging technology that helps to improve our understanding of plant biochemistry and metabolic pathways by delivering accurate measurements, prior to bioinformatics data analysis, of known metabolites. Hemigraphis alternata (H.alternata), commonly known as Red flame ivy, is frequently used in the Indian Traditional Ayurvedic System of Medicine for wound healing but pharmacologically active plant components and action mechanisms of wound healing are yet to be determined. Mass spectrometry-based metabolomic analysis of H. alternata leaf extract identified 24,203 spectra from positive and negative polarities matched to 2285 known metabolites.
DOI: 10.6084/m9.figshare.16448661
title: Supplementary Material for: Adjuvant Radiotherapy for Extrahepatic Cholangiocarcinoma: A Quality Assessment-Based Meta-Analysis

description: <b><i>Introduction:</i></b> The benefits of adjuvant radiotherapy (ART) for extrahepatic cholangiocarcinoma are uncertain largely because existing publications lack clear comparisons between ART and non-ART arms. <b><i>Methods:</i></b> PubMed, Medline, Embase, and the Cochrane library were systematically searched until December 2020. The primary endpoint was overall survival (OS). Sensitivity analysis was performed for studies with reliable comparability (i.e., no favorable prognosticators in the ART arm that could skew the data). <b><i>Results:</i></b> Twenty-three studies involving 1,731 patients with extrahepatic cholangiocarcinoma were reviewed. The overall median of all median prescribed doses was 50.4 Gy; brachytherapy or an intraoperative boost of 10–21 Gy was applied in 5 studies. The pooled 1-, 3-, and 5-year OS rates in the non-ART and ART arms were 69.2% versus 81.0%, <i>p</i> = 0.035; 34.3% versus 44.7%, <i>p</i> = 0.025; 25.6% versus 31.7%, <i>p</i> = 0.115, respectively. The corresponding pooled locoregional recurrence rates were 52.1% versus 34.9% (<i>p</i> = 0.014). The pooled rate of grade ≥3 gastrointestinal complications was 9.8%. Sensitivity analysis performed on 14 eligible studies showed that the ART arms had a lower pooled R0 rate (36.8% vs. 63.2%, <i>p</i> = 0.02) and a higher rate of positive lymph nodes (47.4% vs. 34.9%, <i>p</i> = 0.08). The pooled 1-, 3-, and 5-year OS rates in the non-ART versus ART arms of the selected studies were 78.2% versus 84.9%, <i>p</i> = 0.143; 38.5% versus 49.2%, <i>p</i> = 0.026; and 27.8% versus 34.5%, <i>p</i> = 0.11, respectively. <b><i>Conclusions:</i></b> ART was shown to improve OS in all studies and in those selected for their reliable comparability.
DOI: 10.6084/m9.figshare.16448481
title: Supplementary Material for: Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell Carcinoma

description: <b><i>Objective:</i></b> The aim of the study was to evaluate the prognostic impact of trial-eligibility criteria on outcome in real-world metastatic renal cell carcinoma (mRCC) patients treated with tyrosine kinase inhibitors (TKIs). <b><i>Patients and Methods:</i></b> mRCC patients treated with TKIs as first-line systemic therapy were retrospectively evaluated. The patients were determined as trial-ineligible when they met at least 1 following trial-ineligible criteria; Karnofsky performance status score &lt;70, hemoglobin &lt;9.0 g/dL, creatinine &gt;2.4 mg/dL (male) or &gt;2.0 mg/dL (female), calcium &gt;12.0 mg/dL, platelet &lt;100,000 /μL, neutrophil &lt;1,500 /μL, nonclear-cell histology, and brain metastasis. <b><i>Results:</i></b> Of 238 patients, 101 patients (42%) were determined as trial-ineligible. Progression-free survival (PFS) and overall survival (OS) after the TKI initiation were significantly shorter in the trial-ineligible patients than in the trial-eligible patients (median PFS: 5.53 vs. 15.8 months, <i>p</i> &lt; 0.0001; OS: 13.8 vs. 43.4 months, <i>p</i> &lt; 0.0001). Objective response rate was also significantly lower in the trial-ineligible patients (15% vs. 37%, <i>p</i> = 0.0003). Multivariate analysis further showed that the trial-eligibility was an independent factor for PFS (hazard ratio [HR]: 2.46, <i>p</i> &lt; 0.0001) and OS (HR: 2.39, <i>p</i> &lt; 0.0001). In addition, the number of trial-ineligible factors were negatively correlated with PFS and OS. <b><i>Conclusions:</i></b> In real-word, the substantial number of mRCC patients did not meet the trial-eligibility criteria, and their outcome was worse than that in the trial-eligible patients. Further studies focusing on the outcome in real-world trial-ineligible patients in the immune checkpoint inhibitor era are warranted.
DOI: 10.6084/m9.figshare.16448481.v1
title: Supplementary Material for: Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell Carcinoma

description: <b><i>Objective:</i></b> The aim of the study was to evaluate the prognostic impact of trial-eligibility criteria on outcome in real-world metastatic renal cell carcinoma (mRCC) patients treated with tyrosine kinase inhibitors (TKIs). <b><i>Patients and Methods:</i></b> mRCC patients treated with TKIs as first-line systemic therapy were retrospectively evaluated. The patients were determined as trial-ineligible when they met at least 1 following trial-ineligible criteria; Karnofsky performance status score &lt;70, hemoglobin &lt;9.0 g/dL, creatinine &gt;2.4 mg/dL (male) or &gt;2.0 mg/dL (female), calcium &gt;12.0 mg/dL, platelet &lt;100,000 /μL, neutrophil &lt;1,500 /μL, nonclear-cell histology, and brain metastasis. <b><i>Results:</i></b> Of 238 patients, 101 patients (42%) were determined as trial-ineligible. Progression-free survival (PFS) and overall survival (OS) after the TKI initiation were significantly shorter in the trial-ineligible patients than in the trial-eligible patients (median PFS: 5.53 vs. 15.8 months, <i>p</i> &lt; 0.0001; OS: 13.8 vs. 43.4 months, <i>p</i> &lt; 0.0001). Objective response rate was also significantly lower in the trial-ineligible patients (15% vs. 37%, <i>p</i> = 0.0003). Multivariate analysis further showed that the trial-eligibility was an independent factor for PFS (hazard ratio [HR]: 2.46, <i>p</i> &lt; 0.0001) and OS (HR: 2.39, <i>p</i> &lt; 0.0001). In addition, the number of trial-ineligible factors were negatively correlated with PFS and OS. <b><i>Conclusions:</i></b> In real-word, the substantial number of mRCC patients did not meet the trial-eligibility criteria, and their outcome was worse than that in the trial-eligible patients. Further studies focusing on the outcome in real-world trial-ineligible patients in the immune checkpoint inhibitor era are warranted.
DOI: 10.6084/m9.figshare.14910486.v1
title: Removing Redundant Statements in Amplified Test Cases

description: Test amplification generates new tests by modifying existing, manually written tests. Up until now, this process preserves statements that were relevant for the original test case but are no longer needed for the behavior of the new test case. These unnecessary statements impact the readability of the tests in question. As a part of the effort to make amplified test cases more readable, we investigate dynamic slicing, taint analysis and static analysis as approaches to remove redundant statements. We design and evaluate a simple static analysis approach that we implemented as part of DSpot. Our empirical evaluation on 274 amplified test cases shows that the implemented approach works well: while being rudimentary, it is able to remove a significant portion of the redundant statements in the amplified test cases. While the removal of the statements themselves is relatively fast, verifying that the tests still work as intended through mutation testing is still resource-intensive.
DOI: 10.6084/m9.figshare.14910486.v2
title: Removing Redundant Statements in Amplified Test Cases

description: Test amplification generates new tests by modifying existing, manually written tests. Up until now, this process preserves statements that were relevant for the original test case but are no longer needed for the behavior of the new test case. These unnecessary statements impact the readability of the tests in question. As a part of the effort to make amplified test cases more readable, we investigate dynamic slicing, taint analysis and static analysis as approaches to remove redundant statements. We design and evaluate a simple static analysis approach that we implemented as part of DSpot. Our empirical evaluation on 274 amplified test cases shows that the implemented approach works well: while being rudimentary, it is able to remove a significant portion of the redundant statements in the amplified test cases. While the removal of the statements themselves is relatively fast, verifying that the tests still work as intended through mutation testing is still resource-intensive.
DOI: 10.5281/zenodo.5267179
title: DATASET RELATED TO ARTICLE "MILD MALFORMATION OF CORTICAL DEVELOPMENT WITH OLIGODENDROGLIAL HYPERPLASIA (MOGHE): NEUROPHYSIOLOGICAL FINGERPRINTS OF A NEW PATHOLOGICAL ENTITY"

description: ppt: scalp eeg – brain mri – brain fdg-pet
description: STUDY SUPPORTED BY ITALIAN MINISTRY OF HEALTH (GRANT NET2013-02355313)
DOI: 10.5281/zenodo.5267177
title: DATASET RELATED TO ARTICLE "MILD MALFORMATION OF CORTICAL DEVELOPMENT WITH OLIGODENDROGLIAL HYPERPLASIA (MOGHE): NEUROPHYSIOLOGICAL FINGERPRINTS OF A NEW PATHOLOGICAL ENTITY"

description: ppt: scalp eeg – brain mri – brain fdg-pet
description: STUDY SUPPORTED BY ITALIAN MINISTRY OF HEALTH (GRANT NET2013-02355313)
DOI: 10.48370/ofd/qkrhzx/0maypo
title: MRIPAS_coll_167034_BisonBonasus_1999_F_ad_jaw_scan3D.stl

description: :unav
DOI: 10.48370/ofd/qkrhzx/z6ybuk
title: MRIPAS_coll_167034_BisonBonasus_1999_F_ad_skull_1_scan3D.stl

description: :unav
DOI: 10.48370/ofd/qkrhzx/3ugttk
title: MRIPAS_coll_167034_BisonBonasus_1999_F_ad_skull_2_scan3D.stl

description: :unav
DOI: 10.48370/ofd/qkrhzx
title: Bison bonasus - 167034, Zoological collection of the Mammal Research Institute, PAS

description: Bison bonasus (European bison) from Zoological collection of the Mammal Research Institute, PAS. Collected 1999-01-13. in: Białowieża Forest, 391, Poland. Material type: skull, jaw
DOI: 10.5517/ccdc.csd.cc22bbnf
title: CCDC 1916564: Experimental Crystal Structure Determination

description: Related Article: Alexandru Topor, Dan Liu, Catalin Maxim, Ghenadie Novitchi, Cyrille Train, Zeid A. AlOthman, Abdullah A. S. Al-Kahtani, Liviu Ungur, Le Tuan Anh Ho, Liviu F. Chibotaru, Marius Andruh|2021|J.Mater.Chem.C|9|10912|doi:10.1039/D1TC00894C
DOI: 10.5517/ccdc.csd.cc22bbpg
title: CCDC 1916565: Experimental Crystal Structure Determination

description: Related Article: Alexandru Topor, Dan Liu, Catalin Maxim, Ghenadie Novitchi, Cyrille Train, Zeid A. AlOthman, Abdullah A. S. Al-Kahtani, Liviu Ungur, Le Tuan Anh Ho, Liviu F. Chibotaru, Marius Andruh|2021|J.Mater.Chem.C|9|10912|doi:10.1039/D1TC00894C
DOI: 10.5517/ccdc.csd.cc22bbqh
title: CCDC 1916566: Experimental Crystal Structure Determination

description: Related Article: Alexandru Topor, Dan Liu, Catalin Maxim, Ghenadie Novitchi, Cyrille Train, Zeid A. AlOthman, Abdullah A. S. Al-Kahtani, Liviu Ungur, Le Tuan Anh Ho, Liviu F. Chibotaru, Marius Andruh|2021|J.Mater.Chem.C|9|10912|doi:10.1039/D1TC00894C
DOI: 10.5517/ccdc.csd.cc2381p4
title: CCDC 1944155: Experimental Crystal Structure Determination

description: Related Article: Gregory R. Lorzing,  Eric J. Gosselin,  Benjamin A. Trump,  Arthur H. P. York,  Arni Sturluson,  Casey A. Rowland, Glenn P. A. Yap,  Craig M. Brown,  Cory M. Simon,  Eric D. Bloch|2019|J.Am.Chem.Soc.|141|12128|doi:10.1021/jacs.9b05872
DOI: 10.5517/ccdc.csd.cc2381s7
title: CCDC 1944158: Experimental Crystal Structure Determination

description: Related Article: Gregory R. Lorzing,  Eric J. Gosselin,  Benjamin A. Trump,  Arthur H. P. York,  Arni Sturluson,  Casey A. Rowland, Glenn P. A. Yap,  Craig M. Brown,  Cory M. Simon,  Eric D. Bloch|2019|J.Am.Chem.Soc.|141|12128|doi:10.1021/jacs.9b05872
DOI: 10.5517/ccdc.csd.cc2450ly
title: CCDC 1971029: Experimental Crystal Structure Determination

description: Related Article: Jian Cao, Hua-Chun Wang, Xiancheng Ren, Yun-Xiang Xu|2021|Dyes Pigm.|195|109668|doi:10.1016/j.dyepig.2021.109668
DOI: 10.5517/ccdc.csd.cc2450mz
title: CCDC 1971030: Experimental Crystal Structure Determination

description: Related Article: Jian Cao, Hua-Chun Wang, Xiancheng Ren, Yun-Xiang Xu|2021|Dyes Pigm.|195|109668|doi:10.1016/j.dyepig.2021.109668
DOI: 10.5517/ccdc.csd.cc2450n0
title: CCDC 1971031: Experimental Crystal Structure Determination

description: Related Article: Jian Cao, Hua-Chun Wang, Xiancheng Ren, Yun-Xiang Xu|2021|Dyes Pigm.|195|109668|doi:10.1016/j.dyepig.2021.109668
DOI: 10.5517/ccdc.csd.cc2761gz
title: CCDC 2061390: Experimental Crystal Structure Determination

description: Related Article: Robert Jankowski, Jakub J. Zakrzewski, Mikolaj Zychowicz, Junhao Wang, Yurie Oki, Shin-ichi Ohkoshi, Szymon Chorazy, Barbara Sieklucka|2021|J.Mater.Chem.C|9|10705|doi:10.1039/D1TC00825K
DOI: 10.5517/ccdc.csd.cc2761h0
title: CCDC 2061391: Experimental Crystal Structure Determination

description: Related Article: Robert Jankowski, Jakub J. Zakrzewski, Mikolaj Zychowicz, Junhao Wang, Yurie Oki, Shin-ichi Ohkoshi, Szymon Chorazy, Barbara Sieklucka|2021|J.Mater.Chem.C|9|10705|doi:10.1039/D1TC00825K
DOI: 10.5517/ccdc.csd.cc27b0tf
title: CCDC 2065214: Experimental Crystal Structure Determination

description: Related Article: So Yokomori, Shun Dekura, Akira Ueda, Reiji Kumai, Youichi Murakami, Hatsumi Mori|2021|J.Mater.Chem.C|9|10718|doi:10.1039/D1TC01111A
DOI: 10.5517/ccdc.csd.cc27b0vg
title: CCDC 2065215: Experimental Crystal Structure Determination

description: Related Article: So Yokomori, Shun Dekura, Akira Ueda, Reiji Kumai, Youichi Murakami, Hatsumi Mori|2021|J.Mater.Chem.C|9|10718|doi:10.1039/D1TC01111A
DOI: 10.5517/ccdc.csd.cc27b0wh
title: CCDC 2065216: Experimental Crystal Structure Determination

description: Related Article: So Yokomori, Shun Dekura, Akira Ueda, Reiji Kumai, Youichi Murakami, Hatsumi Mori|2021|J.Mater.Chem.C|9|10718|doi:10.1039/D1TC01111A
DOI: 10.5517/ccdc.csd.cc27b0xj
title: CCDC 2065217: Experimental Crystal Structure Determination

description: Related Article: So Yokomori, Shun Dekura, Akira Ueda, Reiji Kumai, Youichi Murakami, Hatsumi Mori|2021|J.Mater.Chem.C|9|10718|doi:10.1039/D1TC01111A
DOI: 10.5517/ccdc.csd.cc27b0zl
title: CCDC 2065219: Experimental Crystal Structure Determination

description: Related Article: So Yokomori, Shun Dekura, Akira Ueda, Reiji Kumai, Youichi Murakami, Hatsumi Mori|2021|J.Mater.Chem.C|9|10718|doi:10.1039/D1TC01111A
DOI: 10.5517/ccdc.csd.cc27dk8h
title: CCDC 2067646: Experimental Crystal Structure Determination

description: Related Article: Lorenzo Pandolfi, Andrea Giunchi, Arianna Rivalta, Simone D'Agostino, Raffaele Guido Della Valle, Marta Mas-Torrent, Massimilano Lanzi, Elisabetta Venuti, Tommaso Salzillo|2021|J.Mater.Chem.C|9|10865|doi:10.1039/D1TC01313K
DOI: 10.5517/ccdc.csd.cc27dk9j
title: CCDC 2067647: Experimental Crystal Structure Determination

description: Related Article: Lorenzo Pandolfi, Andrea Giunchi, Arianna Rivalta, Simone D'Agostino, Raffaele Guido Della Valle, Marta Mas-Torrent, Massimilano Lanzi, Elisabetta Venuti, Tommaso Salzillo|2021|J.Mater.Chem.C|9|10865|doi:10.1039/D1TC01313K
DOI: 10.5517/ccdc.csd.cc27fmjv
title: CCDC 2068677: Experimental Crystal Structure Determination

description: Related Article: Flavia Pop, Cécile Mézière, Magali Allain, Pascale Auban-Senzier, Naoya Tajima, Daichi Hirobe, Hiroshi M. Yamamoto, Enric Canadell, Narcis Avarvari|2021|J.Mater.Chem.C|9|10777|doi:10.1039/D1TC01112J
DOI: 10.5517/ccdc.csd.cc27fmnz
title: CCDC 2068681: Experimental Crystal Structure Determination

description: Related Article: Flavia Pop, Cécile Mézière, Magali Allain, Pascale Auban-Senzier, Naoya Tajima, Daichi Hirobe, Hiroshi M. Yamamoto, Enric Canadell, Narcis Avarvari|2021|J.Mater.Chem.C|9|10777|doi:10.1039/D1TC01112J
DOI: 10.5517/ccdc.csd.cc27fmq1
title: CCDC 2068683: Experimental Crystal Structure Determination

description: Related Article: Flavia Pop, Cécile Mézière, Magali Allain, Pascale Auban-Senzier, Naoya Tajima, Daichi Hirobe, Hiroshi M. Yamamoto, Enric Canadell, Narcis Avarvari|2021|J.Mater.Chem.C|9|10777|doi:10.1039/D1TC01112J
DOI: 10.5517/ccdc.csd.cc27gt2m
title: CCDC 2069810: Experimental Crystal Structure Determination

description: Related Article: Wei-Jian Xu, Konstantin Romanyuk, Ying Zeng, Andrei Ushakov, Vladimir Shur, Alexander Tselev, Wei-Xiong Zhang, Xiao-Ming Chen, Andrei Kholkin, João Rocha|2021|J.Mater.Chem.C|9|10741|doi:10.1039/D1TC01261D
DOI: 10.5517/ccdc.csd.cc27gt3n
title: CCDC 2069811: Experimental Crystal Structure Determination

description: Related Article: Wei-Jian Xu, Konstantin Romanyuk, Ying Zeng, Andrei Ushakov, Vladimir Shur, Alexander Tselev, Wei-Xiong Zhang, Xiao-Ming Chen, Andrei Kholkin, João Rocha|2021|J.Mater.Chem.C|9|10741|doi:10.1039/D1TC01261D
DOI: 10.5517/ccdc.csd.cc27gsxf
title: CCDC 2069805: Experimental Crystal Structure Determination

description: Related Article: Paula Gómez, Jesús Cerdá, Miriam Más-Montoya, Stamatis Georgakopoulos, Iván da Silva, Antonio García, Enrique Ortí, Juan Aragó, David Curiel|2021|J.Mater.Chem.C|9|10819|doi:10.1039/D1TC01328A
DOI: 10.5517/ccdc.csd.cc27gsyg
title: CCDC 2069806: Experimental Crystal Structure Determination

description: Related Article: Paula Gómez, Jesús Cerdá, Miriam Más-Montoya, Stamatis Georgakopoulos, Iván da Silva, Antonio García, Enrique Ortí, Juan Aragó, David Curiel|2021|J.Mater.Chem.C|9|10819|doi:10.1039/D1TC01328A
DOI: 10.5517/ccdc.csd.cc27ll2j
title: CCDC 2073437: Experimental Crystal Structure Determination

description: Related Article: Nora Gildemeister, Gaetano Ricci, Lukas Böhner, Jörg M. Neudörfl, Dirk Hertel, Frank Würthner, Fabrizia Negri, Klaus Meerholz, Daniele Fazzi|2021|J.Mater.Chem.C|9|10851|doi:10.1039/D1TC01511G
DOI: 10.5517/ccdc.csd.cc27ll3k
title: CCDC 2073438: Experimental Crystal Structure Determination

description: Related Article: Nora Gildemeister, Gaetano Ricci, Lukas Böhner, Jörg M. Neudörfl, Dirk Hertel, Frank Würthner, Fabrizia Negri, Klaus Meerholz, Daniele Fazzi|2021|J.Mater.Chem.C|9|10851|doi:10.1039/D1TC01511G
DOI: 10.5517/ccdc.csd.cc27llv9
title: CCDC 2073461: Experimental Crystal Structure Determination

description: Related Article: Nora Gildemeister, Gaetano Ricci, Lukas Böhner, Jörg M. Neudörfl, Dirk Hertel, Frank Würthner, Fabrizia Negri, Klaus Meerholz, Daniele Fazzi|2021|J.Mater.Chem.C|9|10851|doi:10.1039/D1TC01511G
DOI: 10.5517/ccdc.csd.cc27bfdf
title: CCDC 2065604: Experimental Crystal Structure Determination

description: Related Article: Qian Zou, Tao Shang, Xin-Da Huang, Qing-Qing Guo, Jia-Ge Jia, Song-Song Bao, Yi-Quan Zhang, Li-Min Zheng|2021|J.Mater.Chem.C|9|10749|doi:10.1039/D1TC01027A
DOI: 10.5517/ccdc.csd.cc27bfgh
title: CCDC 2065606: Experimental Crystal Structure Determination

description: Related Article: Qian Zou, Tao Shang, Xin-Da Huang, Qing-Qing Guo, Jia-Ge Jia, Song-Song Bao, Yi-Quan Zhang, Li-Min Zheng|2021|J.Mater.Chem.C|9|10749|doi:10.1039/D1TC01027A
DOI: 10.5517/ccdc.csd.cc27bffg
title: CCDC 2065605: Experimental Crystal Structure Determination

description: Related Article: Qian Zou, Tao Shang, Xin-Da Huang, Qing-Qing Guo, Jia-Ge Jia, Song-Song Bao, Yi-Quan Zhang, Li-Min Zheng|2021|J.Mater.Chem.C|9|10749|doi:10.1039/D1TC01027A
DOI: 10.5281/zenodo.5267397
title: Data used in "Qubit Readout Error Mitigation with Bit-flip Averaging"

description: This data supports "Qubit Readout Error Mitigation with Bit-flip Averaging" by Alistair Smith, Kiran Khosla, Chris Self, and M. S. Kim (arXiv:2106.05800). Included are the measurement results obtained from 1-8 qubit calibration measurements on the <em>ibmq_manhattan</em> device (on 1st Dec 2020), which were used to define the "exact" device response matrices used in the paper. Also included are the results of the numerical simulations used to generate the data for figures 3, 4, and 5.
DOI: 10.5281/zenodo.5267396
title: Data used in "Qubit Readout Error Mitigation with Bit-flip Averaging"

description: This data supports "Qubit Readout Error Mitigation with Bit-flip Averaging" by Alistair Smith, Kiran Khosla, Chris Self, and M. S. Kim (arXiv:2106.05800). Included are the measurement results obtained from 1-8 qubit calibration measurements on the <em>ibmq_manhattan</em> device (on 1st Dec 2020), which were used to define the "exact" device response matrices used in the paper. Also included are the results of the numerical simulations used to generate the data for figures 3, 4, and 5.